Programme Mentors
-(8).jpg)
Paul Gilson
A Medical Device Entrepreneur, Paul has raised over €150 million of VC and Corporate funds in the UK, the US, the EU, and Ireland. He has successfully co-founded and exited three start-up companies.
Co-founder and CSO at Novate Medical, a Galway-based medical device company developing IVC filter technology recently acquired by BTG Medical. He also co-founded Veryan Medical, an Imperial College London spin-out that was acquired in 2018 by Otsuka Medical Devices. Previously, he was a co-founder and General Manager of MedNova and was responsible for the development of novel stroke treatment technologies. The company was acquired by Abbott Laboratories in 2006.
In addition, Paul was Chairman of Embo Medical a spinout from the BioInnovate Programme, which was acquired by C.R. BARD in 2015. Prior to his experience in start-up companies he held a number of senior roles in Operations and R&D. He was Director of R&D for Bard Cardiology where he led the development of numerous cardiovascular devices.
He currently holds board and chairman roles at a number of Medtech start-ups, Bluedrop, Selio Medical, Ostoform, InVera Medical, Kite Medical and Proverum.
Paul has extensive experience in licensing and IP portfolio management and is the holder of more than 60 US patents for biomaterials and cardiovascular products.
